Product Details
Cefoperazone sodium + sulbactam injection
500MG+500MG / 1GM+500MG
Product Description :
CEFOPERAZONE SODIUM + SULBACTAM INJECTION
500 mg + 500 mg / 1 g + 500 mg
Sterile Powder for Solution for Intravenous or Intramuscular Administration
COMPOSITION
Each vial contains:
Cefoperazone Sodium equivalent to Cefoperazone ............... 500 mg
Sulbactam Sodium equivalent to Sulbactam ............... 500 mg
or
Cefoperazone Sodium equivalent to Cefoperazone ............... 1 g
Sulbactam Sodium equivalent to Sulbactam ............... 500 mg
Excipients: As applicable.
PHARMACEUTICAL FORM
Sterile, white to off-white powder for solution for intravenous or intramuscular administration.
THERAPEUTIC CLASS
Third-Generation Cephalosporin Antibiotic + β-Lactamase Inhibitor
INDICATIONS
Cefoperazone Sodium + Sulbactam Injection is indicated for the treatment of moderate to severe bacterial infections caused by susceptible microorganisms.
It may be used in the treatment of:
• Lower respiratory tract infections
• Urinary tract infections
• Intra-abdominal infections
• Skin and soft-tissue infections
• Bone and joint infections
• Biliary tract infections
• Septicemia and bloodstream infections
• Gynecological infections
• Other serious infections caused by susceptible bacteria
Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.
CONTRAINDICATIONS
Cefoperazone Sodium + Sulbactam is contraindicated in patients with known hypersensitivity to cefoperazone, sulbactam, other cephalosporins, penicillins, or any component of the formulation.
DRUG INTERACTIONS
Particular consideration may be required with concomitant use of:
• Anticoagulants such as warfarin
• Aminoglycoside antibiotics
• Other nephrotoxic medicines
• Other β-lactam antibiotics
• Alcohol-containing products
The treating physician should review all concomitant medications before administration.
ADMINISTRATION
Cefoperazone Sodium + Sulbactam Injection may be administered by intravenous or intramuscular route according to the approved product information.
The contents of the vial should be reconstituted with a suitable compatible diluent under appropriate aseptic conditions.
For intravenous administration, the reconstituted solution should be further diluted as required and administered by a qualified healthcare professional according to the approved product information and institutional protocol.
For Intravenous or Intramuscular Use Only.
STORAGE
Store according to the storage conditions stated on the approved product label.
Protect from excessive heat, moisture and light.